Cargando…
SARS‐CoV‐2, aging, and Post‐COVID‐19 neurodegeneration
As the world continues to experience the effects of SARS‐CoV‐2, there is evidence to suggest that the sequelae of viral infection (the post‐COVID‐19 condition; PCC) at both an individual and population level will be significant and long‐lasting. The history of pandemics or epidemics in the last 100 ...
Autor principal: | Strong, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877664/ https://www.ncbi.nlm.nih.gov/pubmed/36458986 http://dx.doi.org/10.1111/jnc.15736 |
Ejemplares similares
-
SARS-CoV-2, COVID-19 and Neurodegeneration
por: Tönges, Lars, et al.
Publicado: (2022) -
SARS-CoV-2, long COVID, prion disease and neurodegeneration
por: Zhao, Yuhai, et al.
Publicado: (2022) -
Creutzfeldt–Jakob disease in a post-COVID-19 patient: did SARS-CoV-2 accelerate the neurodegeneration?
por: Alloush, Taha K., et al.
Publicado: (2023) -
The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021) -
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
por: Krey, Lea, et al.
Publicado: (2021)